{"transactions":[{"id":1774503,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-09-22T20:36:31.000Z","date":"2023-09-21","kind":"grant","planned":false,"acquired":true,"shares":32900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in twelve equal monthly installments commencing on October 21, 2023."}],"balance_after":32900,"derivative":{"exercise_price":8.34,"expiration_date":"2033-09-21","underlying":"Common Stock","underlying_shares":32900},"source":{"system":"sec-edgar","filing":"0001600620-23-000042","document":"wk-form4_1695414981.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062023000042/wk-form4_1695414981.xml","form_type":"4"}},{"id":1774502,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-09-22T20:36:31.000Z","date":"2023-09-21","kind":"grant","planned":false,"acquired":true,"shares":20383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest one year from date of grant and have no expiration date. Vested shares will be delivered on September 21, 2024"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest one year from date of grant and have no expiration date. Vested shares will be delivered on September 21, 2024"}],"balance_after":20383,"derivative":{"underlying":"Common Stock","underlying_shares":20383},"source":{"system":"sec-edgar","filing":"0001600620-23-000042","document":"wk-form4_1695414981.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062023000042/wk-form4_1695414981.xml","form_type":"4"}},{"id":1777014,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common Stock","published_at":"2023-09-19T13:01:30.000Z","date":"2023-09-18","kind":"purchase","planned":false,"acquired":true,"shares":1600,"price":5.6,"value":8960.0,"ownership":{"direct":true},"balance_after":50470,"source":{"system":"sec-edgar","filing":"0001104659-23-101784","document":"tm2326377-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465923101784/tm2326377-1_4seq1.xml","form_type":"4"}},{"id":1778653,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,CSO and Director"}}],"security":"Common Stock","published_at":"2023-09-18T12:00:24.000Z","date":"2023-09-15","kind":"purchase","planned":false,"acquired":true,"shares":1600,"price":5.4,"value":8640.0,"ownership":{"direct":true},"balance_after":48870,"source":{"system":"sec-edgar","filing":"0001104659-23-101391","document":"tm2326273-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465923101391/tm2326273-1_4seq1.xml","form_type":"4"}},{"id":2702500,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CSO and Director"}}],"security":"Stock Options","published_at":"2021-05-20T20:36:01.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":1900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"633,333 of the stock options vest on 5/18/2022 and the remainder vests monthly in equal amounts over 24 months."}],"balance_after":2501879,"derivative":{"exercise_price":1.7,"expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":1900000},"source":{"system":"sec-edgar","filing":"0001104659-21-069939","document":"tm2117144-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465921069939/tm2117144-5_4seq1.xml","form_type":"4"}},{"id":2848845,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common Stock","published_at":"2021-02-18T21:05:53.000Z","date":"2021-02-18","kind":"purchase","acquired":true,"shares":20000,"price":2,"value":40000.0,"ownership":{"direct":true},"balance_after":45259,"source":{"system":"sec-edgar","filing":"0001104659-21-025199","document":"tm217063-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465921025199/tm217063-2_4seq1.xml","form_type":"4"}},{"id":2953024,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common Stock","published_at":"2020-12-08T18:56:11.000Z","date":"2020-12-08","kind":"purchase","acquired":true,"shares":25000,"price":1.5767,"value":39417.5,"ownership":{"direct":true},"balance_after":25259,"source":{"system":"sec-edgar","filing":"0001104659-20-133141","document":"tm2037967-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465920133141/tm2037967-1_4seq1.xml","form_type":"4"}},{"id":3049587,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,CSO and Director"}}],"security":"Stock Options","published_at":"2020-08-21T20:17:58.000Z","date":"2020-08-19","kind":"grant","acquired":true,"shares":212000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"70,667 of the stock options vest on 8/19/2021 and the remainder vests monthly in equal amounts over 24 months."}],"balance_after":601879,"derivative":{"exercise_price":3.72,"expiration_date":"2030-08-19","underlying":"Common Stock","underlying_shares":212000},"source":{"system":"sec-edgar","filing":"0001104659-20-097602","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465920097602/a4.xml","form_type":"4"}},{"id":3180364,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CSO"}}],"security":"Stock Options","published_at":"2020-04-07T20:13:56.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":380000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"126,667 of the stock options vest on 4/3/2021 and the remainder vests monthly in equal amounts over 24 months."}],"balance_after":389879,"derivative":{"exercise_price":1.63,"expiration_date":"2030-04-03","underlying":"Common Stock","underlying_shares":380000},"source":{"system":"sec-edgar","filing":"0001104659-20-044170","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465920044170/a4.xml","form_type":"4"}},{"id":3455809,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CSO"}}],"security":"Stock Options","published_at":"2019-07-25T20:15:22.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":9700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in three installments as follows: 3,233 vest on each of July 24, 2020 and 2021 and 3,234 vest on July 24, 2022."}],"balance_after":9879,"derivative":{"exercise_price":3.24,"expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":9700},"source":{"system":"sec-edgar","filing":"0001104659-19-041844","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465919041844/a4.xml","form_type":"4"}},{"id":4105021,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-01-05T18:08:53.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":100654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan.  All of the shares vested upon grant.  Such shares were issued in lieu of a cash bonus to the reporting person."}],"balance_after":144736,"source":{"system":"sec-edgar","filing":"0001104659-18-000922","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465918000922/a4.xml","form_type":"4"}},{"id":4260673,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":109482,"kind":"person","name":"Foster Robert T","position":1,"cik":"0001677370","reported_name":"Foster Robert T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-07-07T21:00:43.000Z","date":"2017-07-06","kind":"grant","acquired":true,"shares":44082,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan.  All of the shares vested upon grant.  Such shares were issued in lieu of a cash bonus to the reporting person."}],"balance_after":44082,"source":{"system":"sec-edgar","filing":"0001104659-17-044097","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465917044097/a4.xml","form_type":"4"}}]}